Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Teva
Harvard Business School
Queensland Health
Chinese Patent Office
Healthtrust
Cantor Fitzgerald
McKesson
Boehringer Ingelheim

Generated: June 17, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: olaparib

« Back to Dashboard

olaparib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca Pharms LYNPARZA olaparib CAPSULE;ORAL 206162 NDA AstraZeneca Pharmaceuticals LP N 0310-0657-58
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP N 0310-0668-12
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP N 0310-0668-60
Astrazeneca Pharms LYNPARZA olaparib TABLET;ORAL 208558 NDA AstraZeneca Pharmaceuticals LP N 0310-0679-12
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Mallinckrodt
Cerilliant
Covington
Healthtrust
Boehringer Ingelheim
Fuji
McKesson